Expression and Purification of Biologically Active Human Bone Morphogenetic Protein-4 in Recombinant Chinese Hamster Ovary Cells |
Cha, Minyub
(Graduate School of Biotechnology, Kyung Hee University)
Han, Nara (Graduate School of Biotechnology, Kyung Hee University) Pi, Jia (Graduate School of Biotechnology, Kyung Hee University) Jeong, Yongsu (Graduate School of Biotechnology, Kyung Hee University) Baek, Kwanghee (Graduate School of Biotechnology, Kyung Hee University) Yoon, Jaeseung (Graduate School of Biotechnology, Kyung Hee University) |
1 | Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA 87: 9843-9847. DOI |
2 | Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534. DOI |
3 | Nelsen SM, Christian JL. 2009. Site-specific cleavage of BMP4 by furin, PC6, and PC7. J. Biol. Chem. 284: 27157-27166. DOI |
4 | Kim CL, Bang YL, Kim YS, Jang JW, Lee GM. 2016. Alleviation of proteolytic degradation of recombinant human bone morphogenetic protein-4 by repeated batch culture of Chinese hamster ovary cells. Process Biochem. 51: 1078-1084. DOI |
5 | Bessa PC, Cerqueira MT, Rada T, Gomes ME, Neves NM, Nobre A, et al. 2009. Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14. Protein Expr. Purif. 63: 89-94. DOI |
6 | Klosch B, Furst W, Kneidinger R, Schuller M, Rupp B, Banerjee A, et al. 2005. Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli. Biotechnol. Lett. 27: 1559-1564. DOI |
7 | Choi B, Lee Y, Pi J, Jeong Y, Baek K, Yoon J. 2015. Overproduction of recombinant human transforming growth factor beta 3 in Chinese hamster ovary cells. Protein Expr. Purif. 110: 102-106. DOI |
8 | Huang Y, Zhen B, Lin Y, Cai Y, Lin Z, Deng C, et al. 2014. Expression of codon optimized human bone morphogenetic protein 4 in Pichia pastoris. Biotechnol. Appl. Biochem. 61: 175-183. DOI |
9 | Kozak M. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 12: 857-872. DOI |
10 | Yoon J, Baek K, Byun T, Park J. 2014. Expression vector animal cells. US Patent Publication No. 20140038233. |
11 | Ciudad CJ, Urlaub G, Chasin LA. 1988. Deletion analysis of the Chinese hamster dihydrofolate reductase gene promoter. J. Biol. Chem. 263: 16274-16282. |
12 | Cui Y, Jean F, Thomas G, Christian JL. 1998. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J. 17: 4735-4743. DOI |
13 | Kim M, Choe S. 2011. BMPs and their clinical potentials. BMP Rep. 44: 619-634. |
14 | Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. 2005. Protein identification and analysis tools on the ExPASy server, pp. 571-607. In Walker J (ed.). The Proteomics Protocols Handbook. Humana, Press, New York. |
15 | Isaacs NW. 1995. Cystine knots. Curr. Opin. Struct. Biol. 5: 391-395. DOI |
16 | Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. 2000. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Invest. 105: 863-873. DOI |
17 | Winnier G, Blessing M, Labosky PA, Hogan BL. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9: 2105-2116. DOI |
18 | Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: a critical review. Cell Signal. 23: 609-620. DOI |
19 | Liu B, Tian D, Yi W, Wu L, Cai Q, Dong H, et al. 2010. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251. Cell Biochem. Biophys. 58: 91-96. DOI |
20 | Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765. DOI |
21 | Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. 2011. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother. Radiopharm. 26: 77-83. DOI |
22 | Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. 2011. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140: 297-309. DOI |
23 | Foster B, Germain B, Hammerstone K. 2003. Novel TGF-beta protein purification methods. US Patent Publication No. 20030036629 A1. |
24 | Zhang F, Ren L, Lin H, Yin M, Tong Y, Shi G. 2012. The optimal dose of recombinant human osteogenic protein-1 enhances differentiation of mouse osteoblast-like cells: an in vitro study. Arch. Oral Biol. 57: 460-468. DOI |
25 | Duggal R, Geissinger U, Zhang Q, Aguilar J, Chen NG, Binda E, et al. 2013. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival. J. Transl. Med. 11: 155. DOI |